← back to news

Other

Cancer blood test developer Freenome to go public in $330M SPAC deal - Fierce Biotech

By Fierce Biotech·Google News·2025-12-05 at 3:00am ET·confidence: low

Read full article ↗

rssspecial_purpose_acquisition